Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.
about
Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered populationOccurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient recordsA randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research databaseOutcomes in the management of atrial fibrillation: clinical trial results can apply in practiceImportance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paperThe safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort studyAnticoagulation for patients with atrial fibrillation. Editorial may have overinterpreted data.Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 PatientsMeasures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic reviewQuality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.Physician compliance with outpatient oral anticoagulant guidelines in Auvergne, France.Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVALUpdate on anti-coagulation in atrial fibrillation.The clinical pharmacology of ageing.Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice.Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin.Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinicsThe impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study.Management of stroke prevention in canadian patients with atrial fibrillation at moderate to high risk of stroke.Preventative Measures of Stroke in Patients With Atrial Fibrillation.How to generalize efficacy results of randomized trials: recommendations based on a systematic review of possible approaches.New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR®) PINNACLE Registry.Development of a bayesian forecasting method for warfarin dose individualization.Antithrombotic treatment in atrial fibrillation.Anticoagulation to prevent stroke in atrial fibrillation. It's still not clear whether results in secondary care translate to primary care.Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enoughThe prestroke use of vitamin K antagonists for atrial fibrillation - trends over 15 years.Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.[Atrial fibrillation, stroke and anticoagulation: under-use of warfarin?].Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism.Secular trends, treatments, and outcomes of Middle Eastern Arab and South Asian patients hospitalized with atrial fibrillation: insights from a 20-year registry in Qatar (1991-2010).Are atrial fibrillation guidelines altering management? A community based study.A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department.Effects of structured patient education on knowledge level and INR control of patients receiving warfarin: Randomized Controlled Trial.
P2860
Q24800042-D006EB78-82BD-4492-8183-1B8611F43A12Q24800847-47F3F027-04C0-4BCC-82E3-7B0143B70006Q24803243-C54C0579-0876-411F-B57B-810C9DDDC12BQ28188181-4FD1C7AA-74E9-4ED4-8486-CF9FD2FA1BDAQ28188553-1CBBC009-6838-4826-A88A-02672839E655Q28188630-F1D3F18E-79DF-454B-B027-7E65E2769B54Q28200425-3956E29D-0051-48B3-B166-D73B6A1647BDQ30616220-E99BE1ED-0D08-431E-A9F3-1F7FA269BE12Q33792405-11C82054-42CA-4C23-BC79-C84C05140717Q33795571-7CB063B4-DE71-43A9-B6F3-CF6BD025C69FQ33891646-34CABD7E-91FB-4FB8-BAC5-9052E1107BFDQ33911000-F23480F9-0507-45C1-92E5-204CD416B5E2Q34742633-4F63B98F-7504-43D8-9B2F-930B905AE10FQ35099559-2926A9E7-D483-4DCA-AB06-F6B4C58102A6Q35172841-D3CB701E-151C-4763-ACF5-18D3686D4F7CQ35200040-535735CF-E8A7-43AF-93CB-3C9E38971790Q35583944-D5703DE4-1DC7-42E0-A8C2-515D6A293825Q35673546-C318ABDD-98CA-4806-A573-CFA72D9A84B9Q35771232-5892BD1F-0C87-44B9-B432-78A121EC146DQ35836747-BA2391CD-1F85-4496-8716-6A08FA945AA2Q36047877-5765C5DA-CD11-442A-BE33-384BBD1D1371Q37116033-D5DE3C96-E824-4798-B1C7-4C9266411BECQ37250616-F92FCABC-96A0-4047-A5CC-DE6D6EB8E29EQ37496186-AC1C0011-B808-4763-8624-A7ACF6829EBAQ38031999-7DCB6C94-C519-4D03-8FE6-7322BB75D38AQ38061141-66E37256-8B21-446A-A23A-9F6A4B90FCD4Q38081149-E09B63F4-ED22-45AA-94FA-440EAB048426Q38671483-215A92A1-41E0-4719-96F3-6A794B218CB5Q39785314-E0A72BA2-9601-425C-84CC-ADD8038A0A93Q41878910-BBBF4BCC-1CEC-4A5F-BB5F-EA400FBA2AECQ41971404-F16DEE01-34D9-499D-8BE7-04703B8DE425Q42767139-2F43C516-C460-4EF2-B20A-F8294151C4A2Q43533823-9DFB9FCB-7B7B-46D8-990B-CD8AB2D5F686Q43762811-E795AEE3-DD89-4306-8326-D26A2B1FA36AQ45194118-14917999-F673-4C9F-BCB7-DBA1F8185BC6Q45230046-3009930C-415F-452E-B4B8-7CE1B4B08EA9Q46091659-34E2773D-FEF8-434F-A0FA-7FC512CA8014Q46865870-AC72076D-F856-404C-9DB6-05FA239D7BD1Q47398263-A4E758BD-8AC9-40D1-BA46-4FA22A06F5C0Q55035293-AA84155D-F56C-4234-92C1-A59255CDD1F0
P2860
Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospective cohort study to de ...... s into clinical effectiveness.
@en
Prospective cohort study to de ...... s into clinical effectiveness.
@nl
type
label
Prospective cohort study to de ...... s into clinical effectiveness.
@en
Prospective cohort study to de ...... s into clinical effectiveness.
@nl
prefLabel
Prospective cohort study to de ...... s into clinical effectiveness.
@en
Prospective cohort study to de ...... s into clinical effectiveness.
@nl
P2093
P2860
P1433
P1476
Prospective cohort study to de ...... s into clinical effectiveness.
@en
P2093
P2860
P304
P356
10.1136/BMJ.320.7244.1236
P407
P577
2000-05-01T00:00:00Z